Brett Dabruzzo

Also affiliated with AbbVie (Japan)

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Rates of Response to Atogepant for Migraine Prophylaxis Among Adults”.

Rates of Response to Atogepant for Migraine Prophylaxis Among Adults

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.15499

N/A

0.808DataRank · unranked

19 citations

Patricia Pozo‐Rosich, Andrew Blumenfeld, David W. Dodick, Peter McAllister, Ye Li +7 more

Early Improvements With Atogepant for the Preventive Treatment of Migraine

Neurology(2024)10.1212/wnl.0000000000210212

N/A

0.514DataRank · unranked

8 citations

Pranav Gandhi, Cristina Tassorelli, Uwe Reuter, Andrea M. Harriott, Dagny Holle +9 more

Novel insight into atogepant mechanisms of action in migraine prevention

Brain(2024)10.1093/brain/awae062

N/A

0DataRank · unranked

29 citations

Andrew M. Strassman, Ron S. Broide, Aubrey Manack Adams, Brett Dabruzzo, Mitchell F. Brin +2 more